ExodusPoint Capital Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.87M | Buy |
241,694
+79,574
| +49% | +$1.27M | 0.03% | 455 |
|
|
2025
Q1 | $2.77M | Buy |
162,120
+132,887
| +455% | +$2.27M | 0.03% | 545 |
|
|
2024
Q4 | $724K | Buy |
+29,233
| New | +$724K | 0.01% | 952 |
|
|
2024
Q3 | – | Sell |
-126,660
| Closed | -$3.34M | – | 1692 |
|
|
2024
Q2 | $3.34M | Buy |
126,660
+57,506
| +83% | +$1.52M | 0.02% | 498 |
|
|
2024
Q1 | $2.23M | Buy |
69,154
+20,249
| +41% | +$654K | 0.02% | 555 |
|
|
2023
Q4 | $2.06M | Buy |
+48,905
| New | +$2.06M | 0.01% | 526 |
|
|
2023
Q3 | – | Sell |
-37,135
| Closed | -$704K | – | 1832 |
|
|
2023
Q2 | $704K | Sell |
37,135
-11,460
| -24% | -$217K | 0.01% | 1140 |
|
|
2023
Q1 | $754K | Buy |
+48,595
| New | +$754K | 0.01% | 1135 |
|
|
2022
Q4 | – | Sell |
-22,776
| Closed | -$127K | – | 1793 |
|
|
2022
Q3 | $127K | Sell |
22,776
-290,580
| -93% | -$1.62M | ﹤0.01% | 1682 |
|
|
2022
Q2 | $1.22M | Buy |
313,356
+15,286
| +5% | +$59.6K | 0.02% | 943 |
|
|
2022
Q1 | $1.64M | Buy |
298,070
+97,026
| +48% | +$534K | 0.02% | 828 |
|
|
2021
Q4 | $1.71M | Buy |
201,044
+67,844
| +51% | +$578K | 0.02% | 785 |
|
|
2021
Q3 | $1.16M | Sell |
133,200
-32,217
| -19% | -$280K | 0.02% | 915 |
|
|
2021
Q2 | $1.75M | Buy |
+165,417
| New | +$1.75M | 0.02% | 690 |
|
|
2020
Q1 | – | Sell |
-21,800
| Closed | -$346K | – | 1291 |
|
|
2019
Q4 | $346K | Buy |
+21,800
| New | +$346K | 0.01% | 1011 |
|